Analysts Reveal a Change in These Share Price Targets Thursday

Wall St. Watchdog reveals information about companies for which stock analysts reiterated their ratings on May 17th.

Pharmacyclics (NASDAQ:PCYC): Rodman & Renshaw reiterated its rating of Mkt Outperform for this company and changed its price target from $22 to $40.

Nu Skin (NYSE:NUS): Stifel Nicolaus reiterated its rating of Buy for this company and changed its price target from $60 to $51.

Informatica (NASDAQ:INFA): Mizuho reiterated its rating of Neutral for this company and changed its price target from $53 to $47.

Abiomed (NASDAQ:ABMD): Wunderlich reiterated its rating of Buy for this company and changed its price target from $27 to $29.

Echelon (NASDAQ:ELON): Cantor Fitzgerald reiterated its rating of Buy for this company and changed its price target from $10 to $5.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.